Opportunity
Federal Register #FMCSA20150115
FMCSA Renews Exemptions for Drivers with Epilepsy and Seizure Disorders
Buyer
Federal Motor Carrier Safety Administration
Posted
May 07, 2026
Respond By
June 08, 2026
Identifier
FMCSA20150115
NAICS
926120
This notice from the Federal Motor Carrier Safety Administration (FMCSA) addresses regulatory exemptions for commercial drivers with epilepsy or seizure disorders: - Government Buyer: - Federal Motor Carrier Safety Administration (FMCSA), Department of Transportation - OEMs and Vendors: - No commercial OEMs or vendors are involved; FMCSA is the responsible agency - Products/Services Requested: - No products or services are being procured; this is a regulatory action - Unique or Notable Requirements: - Exemptions allow 20 individuals with epilepsy or seizure disorders to operate commercial motor vehicles (CMVs) in interstate commerce - Exemptions waive the requirement for drivers to have no history of epilepsy or conditions likely to cause loss of consciousness - Exemptions are valid for 2 years, subject to strict conditions: - Drivers must remain seizure-free and maintain stable treatment - Annual medical reports and examinations are required - Drivers must report any crashes or disqualifying offenses - Public comments are solicited regarding the exemptions - No procurement activity, contract value, or product/service line items are associated with this notice
Description
The Federal Motor Carrier Safety Administration (FMCSA) has renewed exemptions for 20 individuals with epilepsy or seizure disorders, allowing them to operate commercial motor vehicles in interstate commerce despite their medical conditions. These exemptions waive the Federal Motor Carrier Safety Regulations requirement that drivers have no established medical history or clinical diagnosis of epilepsy or any condition likely to cause loss of consciousness. The exemptions are valid for a renewable 2-year period and include specific terms and conditions such as remaining seizure-free and submitting annual medical reports. Comments on this renewal are invited until June 8, 2026.